Zoetis Inc
(XTER:ZOE)
€
161.04
-7.48 (-4.47%)
Market Cap: 72.99 Bil
Enterprise Value: 77.63 Bil
PE Ratio: 34.28
PB Ratio: 15.16
GF Score: 96/100 
Zoetis Inc at Barclays Global Healthcare Conference Transcript
Mar 17, 2022 / 01:30PM GMT
Release Date Price:
€173.9
(+0.58%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
Good morning, everyone. My name is Balaji Prasad. I lead the specialty pharmaceuticals coverage for Barclays, and a part of that responsibility is also the privilege of covering the animal health sector. So today, we have with us Zoetis. And from Zoetis, Wetteny Joseph, the Chief Financial Officer. Wetteny, welcome to our conference.
Wetteny N. Joseph
Zoetis Inc. - Executive VP & CFO
Thank you, Balaji.
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
It's -- we're glad to do it in person. And I know it's also your first in-person conference since you joined Zoetis, so I'm glad to have you here. Maybe just to kickstart, it's probably been around 10 months since you joined Zoetis.
Wetteny N. Joseph
Zoetis Inc. - Executive VP & CFO
That's right.
Questions & Answers
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers